• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

JPM2024: IRA Favors Biologics Over Small Molecule Drugs and Hurts Innovation, Industry...

cafead

Administrator
Staff member
  • cafead   Jan 12, 2024 at 11:42: AM
via Biologics have a major advantage over small molecule drugs under the Inflation Reduction Act’s provisions, according to stakeholders attending this week’s J.P. Morgan conference.

article source
 

<